# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Trulieve Cannabis Corp. announced on Thursday its first quarter results for the three months ended March 31, 2024. The Tallahas...
Barclays analyst Lauren Lieberman maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and raises the price target from...
Wells Fargo analyst Chris Carey maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and raises the price target from $...
BofA Securities analyst Bryan Spillane boosts Colgate-Palmolive's target to $100, citing impressive growth metrics. CL star...
Stifel analyst Mark Astrachan maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $94 to $95.
B of A Securities analyst Bryan Spillane maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $...